Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Addpharma Inc.
Condition or disease : Primary Hypercholesterolemia and Essential Hypertension Intervention/treatment Drug : AD-2021 Drug : AD-2022 Drug : AD-2021 Placebo Drug : AD-2022 Placebo Phase : Phase 3
Age
19–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Signed informed consent
Subjects with hypertension and hyperlipidemia
You may not be if
Patient with known or suspected secondary hypertension
